In the current study, we also showed that MELK-In-17 suppressed the CSC phenotype and reversed EMT in vitro and inhibited tumor growth in mouse models, further supported by the impaired tumor growth in mice bearing xenografts of MDA-MB-231 cells in which MELK was knocked out. Here, MELK is linked to neoplasm.